{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:34:31Z","timestamp":1791646471813,"version":"4.3.4"},"reference-count":208,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,11,17]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel for transport of chloride and bicarbonate anions. Functional roles of CFTR have been identified in a broad range of cell types including epithelial, endothelial, immune and structural cells. While CFTR has been investigated largely in the context of inborn dysfunction in cystic fibrosis, recent evidence shows that CFTR is also affected by acquired dysfunction in COPD. In patients with COPD and smokers, CFTR impairment has been demonstrated in the upper and lower airways, sweat glands and intestines, suggesting both pulmonary and systemic defects. Cigarette smoke, a key factor in COPD development, is the major cause of acquired CFTR dysfunction. Inflammation, bacterial byproducts and reactive oxygen species can further impair CFTR expression and function. CFTR dysfunction could contribute directly to disease manifestation and progression of COPD including disturbed airway surface liquid homeostasis, airway mucus obstruction, pathogen colonisation and inflammation. Mucus plugging and neutrophilic inflammation contribute to tissue destruction, development of dysfunction at the level of the small airways and COPD progression. Acquired CFTR dysfunction in extrapulmonary organs could add to common comorbidities and the disease burden. This review explores how CFTR dysfunction may be acquired and its potential effects on patients with COPD, particularly those with chronic bronchitis. The development of CFTR potentiators and the probable benefits of CFTR potentiation to improve tissue homeostasis, reduce inflammation, improve host defence and potentially reduce remodelling in the lungs will be discussed.<\/jats:p>","DOI":"10.1183\/13993003.01307-2022","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T12:25:13Z","timestamp":1670502313000},"page":"2201307","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond"],"prefix":"10.1183","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-2199","authenticated-orcid":false,"given":"Marcus A.","family":"Mall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.","family":"Criner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-9520","authenticated-orcid":false,"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-0133","authenticated-orcid":false,"given":"Steven M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus F.","family":"Vogelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Rowlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schoenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"2024102103101166000_61.4.2201307.1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.4.110807.092145"},{"key":"2024102103101166000_61.4.2201307.2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17476348.2018.1475235","article-title":"CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease","volume":"12","author":"Fernandez Fernandez","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"2024102103101166000_61.4.2201307.3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccm.2015.11.003","article-title":"Acquired cystic fibrosis transmembrane conductance regulator dysfunction in chronic bronchitis and other diseases of mucus clearance","volume":"37","author":"Raju","year":"2016","journal-title":"Clin Chest Med"},{"key":"2024102103101166000_61.4.2201307.4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00228013"},{"key":"2024102103101166000_61.4.2201307.5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0274"},{"key":"2024102103101166000_61.4.2201307.6","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-192377"},{"key":"2024102103101166000_61.4.2201307.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201304-0733OC"},{"key":"2024102103101166000_61.4.2201307.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00558-2020"},{"key":"2024102103101166000_61.4.2201307.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02645-2020"},{"key":"2024102103101166000_61.4.2201307.10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJMoa2100665","article-title":"Triple therapy for cystic fibrosis Phe508del-gating and -residual function genotypes","volume":"385","author":"Barry","year":"2021","journal-title":"N Engl J Med"},{"key":"2024102103101166000_61.4.2201307.11","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E14-04-0935"},{"key":"2024102103101166000_61.4.2201307.12","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201901-0145OC","article-title":"Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis","volume":"199","author":"McCague","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103101166000_61.4.2201307.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2387-7"},{"key":"2024102103101166000_61.4.2201307.14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/humu.23741","article-title":"Two CFTR mutations within codon 970 differently impact on the chloride channel functionality","volume":"40","author":"Amato","year":"2019","journal-title":"Hum Mutat"},{"key":"2024102103101166000_61.4.2201307.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200508-1330OC"},{"key":"2024102103101166000_61.4.2201307.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039809"},{"key":"2024102103101166000_61.4.2201307.17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1164\/rccm.202109-2064TR","article-title":"Cystic fibrosis transmembrane conductance regulator: roles in chronic obstructive pulmonary disease","volume":"205","author":"Dransfield","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103101166000_61.4.2201307.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201205-0875OC"},{"key":"2024102103101166000_61.4.2201307.19","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.3390\/ijms22095018","article-title":"Proteases, mucus, and mucosal immunity in chronic lung disease","volume":"22","author":"McKelvey","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024102103101166000_61.4.2201307.20","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00007.2018"},{"key":"2024102103101166000_61.4.2201307.21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1164\/rccm.201910-1943SO","article-title":"Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications","volume":"201","author":"Mall","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103101166000_61.4.2201307.22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024102103101166000_61.4.2201307.23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202008-3198OC"},{"key":"2024102103101166000_61.4.2201307.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0394-6"},{"key":"2024102103101166000_61.4.2201307.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0393-7"},{"key":"2024102103101166000_61.4.2201307.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2391-y"},{"key":"2024102103101166000_61.4.2201307.27","doi-asserted-by":"publisher","DOI":"10.1038\/ng1192-240"},{"key":"2024102103101166000_61.4.2201307.28","doi-asserted-by":"crossref","first-page":"10232","DOI":"10.3390\/ijms231810232","article-title":"Mucins and CFTR: their close relationship","volume":"23","author":"Okuda","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024102103101166000_61.4.2201307.29","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00326.2014"},{"key":"2024102103101166000_61.4.2201307.30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/19.19.5417"},{"key":"2024102103101166000_61.4.2201307.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022212"},{"key":"2024102103101166000_61.4.2201307.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019970"},{"key":"2024102103101166000_61.4.2201307.33","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1456"},{"key":"2024102103101166000_61.4.2201307.34","doi-asserted-by":"crossref","first-page":"17066","DOI":"10.1038\/s41598-018-35151-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"2024102103101166000_61.4.2201307.35","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ymthe.2020.12.003","article-title":"Rescue from Pseudomonas aeruginosa airway infection via stem cell transplantation","volume":"29","author":"Brinkert","year":"2021","journal-title":"Mol Ther"},{"key":"2024102103101166000_61.4.2201307.36","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3389\/fimmu.2020.01871","article-title":"Consequences of CRISPR-Cas9-mediated CFTR knockout in human macrophages","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"2024102103101166000_61.4.2201307.37","doi-asserted-by":"crossref","first-page":"L432","DOI":"10.1152\/ajplung.00461.2017","article-title":"Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa","volume":"314","author":"Barnaby","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102103101166000_61.4.2201307.38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3389\/fphar.2020.01219","article-title":"CFTR modulator therapy enhances peripheral blood monocyte contributions to immune responses in people with cystic fibrosis","volume":"11","author":"Hisert","year":"2020","journal-title":"Front Pharmacol"},{"key":"2024102103101166000_61.4.2201307.39","doi-asserted-by":"crossref","first-page":"e54556","DOI":"10.7554\/eLife.54556","article-title":"Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis","volume":"9","author":"Jarosz-Griffiths","year":"2020","journal-title":"eLife"},{"key":"2024102103101166000_61.4.2201307.40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.202106-1426OC","article-title":"Trikafta rescues CFTR and lowers monocyte P2X7R-induced inflammasome activation in cystic fibrosis","volume":"205","author":"Gabillard-Lefort","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103101166000_61.4.2201307.41","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201305-123AW"},{"key":"2024102103101166000_61.4.2201307.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26777-9"},{"issue":"Suppl. 1","key":"2024102103101166000_61.4.2201307.43","doi-asserted-by":"crossref","first-page":"A36","DOI":"10.1186\/1753-6561-9-S1-A36","article-title":"The importance of CFTR expression for neutrophil function in patients with cystic fibrosis","volume":"9","author":"Jundi","year":"2015","journal-title":"BMC Proc"},{"key":"2024102103101166000_61.4.2201307.44","doi-asserted-by":"publisher","DOI":"10.1021\/bi060490t"},{"key":"2024102103101166000_61.4.2201307.45","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.4A0316-130RR"},{"key":"2024102103101166000_61.4.2201307.46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02161-2020"},{"key":"2024102103101166000_61.4.2201307.47","doi-asserted-by":"publisher","DOI":"10.1159\/000295791"},{"key":"2024102103101166000_61.4.2201307.48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.12688\/f1000research.18411.1","article-title":"Understanding the role of neutrophils in chronic inflammatory airway disease","volume":"8","author":"Jasper","year":"2019","journal-title":"F1000Res"},{"key":"2024102103101166000_61.4.2201307.49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/15412555.2018.1476475","article-title":"Neutrophilic inflammation in the pathogenesis of chronic obstructive pulmonary disease","volume":"15","author":"Butler","year":"2018","journal-title":"COPD"},{"key":"2024102103101166000_61.4.2201307.50","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24101"},{"key":"2024102103101166000_61.4.2201307.51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-019-1103-1","article-title":"CFTR regulates B cell activation and lymphoid follicle development","volume":"20","author":"Polverino","year":"2019","journal-title":"Respir Res"},{"key":"2024102103101166000_61.4.2201307.52","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01873-2016"},{"key":"2024102103101166000_61.4.2201307.53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032158"},{"key":"2024102103101166000_61.4.2201307.54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201507-1311OC"},{"key":"2024102103101166000_61.4.2201307.55","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2008.85"},{"key":"2024102103101166000_61.4.2201307.56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064341"},{"key":"2024102103101166000_61.4.2201307.57","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/cells9061371","article-title":"Intrinsic abnormalities of cystic fibrosis airway connective tissue revealed by an in vitro 3D stromal model","volume":"9","author":"Mazio","year":"2020","journal-title":"Cells"},{"key":"2024102103101166000_61.4.2201307.58","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200706-929OC"},{"key":"2024102103101166000_61.4.2201307.59","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jcp.24931","article-title":"Dynamically regulated CFTR expression and its functional role in cutaneous wound healing","volume":"230","author":"Dong","year":"2015","journal-title":"J Cell Physiol"},{"key":"2024102103101166000_61.4.2201307.60","doi-asserted-by":"publisher","DOI":"10.1159\/000447919"},{"key":"2024102103101166000_61.4.2201307.61","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/wound.2018.0927","article-title":"Cystic fibrosis transmembrane conductance regulator: a possible new target for photodynamic therapy enhances wound healing","volume":"8","author":"Chiu","year":"2019","journal-title":"Adv Wound Care"},{"key":"2024102103101166000_61.4.2201307.62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00512"},{"key":"2024102103101166000_61.4.2201307.63","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00202-2017"},{"key":"2024102103101166000_61.4.2201307.64","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201508-1562OC"},{"key":"2024102103101166000_61.4.2201307.65","doi-asserted-by":"crossref","first-page":"L690","DOI":"10.1152\/ajplung.00090.2019","article-title":"Characterization of cystic fibrosis airway smooth muscle cell proliferative and contractile activities","volume":"317","author":"Jang","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102103101166000_61.4.2201307.66","doi-asserted-by":"crossref","first-page":"e86183","DOI":"10.1172\/jci.insight.86183","article-title":"Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities","volume":"1","author":"Adam","year":"2016","journal-title":"JCI Insight"},{"key":"2024102103101166000_61.4.2201307.67","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00653-2020"},{"key":"2024102103101166000_61.4.2201307.68","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S2213-2600(16)30105-9","article-title":"Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study","volume":"4","author":"Wells","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102103101166000_61.4.2201307.69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1421190112"},{"key":"2024102103101166000_61.4.2201307.70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12931-017-0505-1","article-title":"The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD)","volume":"18","author":"Green","year":"2017","journal-title":"Respir Res"},{"key":"2024102103101166000_61.4.2201307.71","doi-asserted-by":"crossref","first-page":"e20200938","DOI":"10.1084\/jem.20200938","article-title":"Reversal of emphysema by restoration of pulmonary endothelial cells","volume":"218","author":"Hisata","year":"2021","journal-title":"J Exp Med"},{"key":"2024102103101166000_61.4.2201307.72","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphys.2020.00879","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) in human lung microvascular endothelial cells controls oxidative stress, reactive oxygen-mediated cell signaling and inflammatory responses","volume":"11","author":"Khalaf","year":"2020","journal-title":"Front Physiol"},{"key":"2024102103101166000_61.4.2201307.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.08.011"},{"key":"2024102103101166000_61.4.2201307.74","doi-asserted-by":"crossref","first-page":"8345246","DOI":"10.1155\/2020\/8345246","article-title":"Upregulation of CFTR protects against palmitate-induced endothelial dysfunction by enhancing autophagic flux","volume":"2020","author":"Chen","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"2024102103101166000_61.4.2201307.75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00261-2020"},{"key":"2024102103101166000_61.4.2201307.76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2147\/COPD.S79638","article-title":"COPD and osteoporosis: links, risks, and treatment challenges","volume":"11","author":"Inoue","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102103101166000_61.4.2201307.77","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw009"},{"key":"2024102103101166000_61.4.2201307.78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080098"},{"key":"2024102103101166000_61.4.2201307.79","doi-asserted-by":"crossref","first-page":"611921","DOI":"10.3389\/fcell.2021.611921","article-title":"Bone cells differentiation: how CFTR mutations may rule the game of stem cells commitment?","volume":"9","author":"Dumortier","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2024102103101166000_61.4.2201307.80","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jcf.2019.10.023","article-title":"CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth","volume":"19","author":"Braux","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2024102103101166000_61.4.2201307.81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188497"},{"key":"2024102103101166000_61.4.2201307.82","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2144LE"},{"key":"2024102103101166000_61.4.2201307.83","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25255"},{"key":"2024102103101166000_61.4.2201307.84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.wjorl.2018.09.001","article-title":"Acquired cystic fibrosis transmembrane conductance regulator dysfunction","volume":"4","author":"Banks","year":"2018","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"2024102103101166000_61.4.2201307.85","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00376.2004"},{"key":"2024102103101166000_61.4.2201307.86","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0226OC"},{"key":"2024102103101166000_61.4.2201307.87","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0432OC"},{"key":"2024102103101166000_61.4.2201307.88","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1164\/rccm.201805-0827LE","article-title":"Maternal smoking induces acquired CFTR dysfunction in neonatal rats","volume":"198","author":"McCormick","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103101166000_61.4.2201307.89","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.07.006"},{"key":"2024102103101166000_61.4.2201307.90","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200509-1377OC"},{"key":"2024102103101166000_61.4.2201307.91","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1998.5272"},{"key":"2024102103101166000_61.4.2201307.92","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-18"},{"key":"2024102103101166000_61.4.2201307.93","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.11.50"},{"key":"2024102103101166000_61.4.2201307.94","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6673-1-11"},{"key":"2024102103101166000_61.4.2201307.95","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/jcm7100335","article-title":"Association between work and chronic obstructive pulmonary disease (COPD)","volume":"7","author":"van der Molen","year":"2018","journal-title":"J Clin Med"},{"key":"2024102103101166000_61.4.2201307.96","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-69"},{"key":"2024102103101166000_61.4.2201307.97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050837"},{"key":"2024102103101166000_61.4.2201307.98","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00113214"},{"key":"2024102103101166000_61.4.2201307.99","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMc1413312","article-title":"Elevated sweat chloride levels due to arsenic toxicity","volume":"372","author":"Mazumdar","year":"2015","journal-title":"N Engl J Med"},{"key":"2024102103101166000_61.4.2201307.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2008.10.059"},{"key":"2024102103101166000_61.4.2201307.101","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22999"},{"key":"2024102103101166000_61.4.2201307.102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcf.2016.02.009","article-title":"Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel","volume":"15","author":"Pesce","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2024102103101166000_61.4.2201307.103","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2011.747"},{"key":"2024102103101166000_61.4.2201307.104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124833"},{"key":"2024102103101166000_61.4.2201307.105","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.035345"},{"key":"2024102103101166000_61.4.2201307.106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047405"},{"key":"2024102103101166000_61.4.2201307.107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089599"},{"key":"2024102103101166000_61.4.2201307.108","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3390\/ijms18081807","article-title":"Signaling cascade involved in rapid stimulation of cystic fibrosis transmembrane conductance regulator (CFTR) by dexamethasone","volume":"18","author":"Bossmann","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2024102103101166000_61.4.2201307.109","doi-asserted-by":"crossref","first-page":"L1186","DOI":"10.1152\/ajplung.2000.278.6.L1186","article-title":"Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-\u03b3","volume":"278","author":"Galietta","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102103101166000_61.4.2201307.110","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan7984"},{"key":"2024102103101166000_61.4.2201307.111","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200312018"},{"key":"2024102103101166000_61.4.2201307.112","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0430OC"},{"key":"2024102103101166000_61.4.2201307.113","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3389\/fphar.2018.01113","article-title":"Emerging microRNA therapeutic approaches for cystic fibrosis","volume":"9","author":"Bardin","year":"2018","journal-title":"Front Pharmacol"},{"key":"2024102103101166000_61.4.2201307.114","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ajpath.2014.12.022","article-title":"New insights about miRNAs in cystic fibrosis","volume":"185","author":"Sonneville","year":"2015","journal-title":"Am J Pathol"},{"key":"2024102103101166000_61.4.2201307.115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106842"},{"key":"2024102103101166000_61.4.2201307.116","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201704-0732OC"},{"key":"2024102103101166000_61.4.2201307.117","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1995.6.4-445"},{"key":"2024102103101166000_61.4.2201307.118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044059"},{"key":"2024102103101166000_61.4.2201307.119","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2007-0452OC"},{"key":"2024102103101166000_61.4.2201307.120","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00015608"},{"key":"2024102103101166000_61.4.2201307.121","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00338-07"},{"key":"2024102103101166000_61.4.2201307.122","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-014-1474-6"},{"key":"2024102103101166000_61.4.2201307.123","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00076214"},{"key":"2024102103101166000_61.4.2201307.124","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fcimb.2017.00470","article-title":"Quorum sensing down-regulation counteracts the negative impact of Pseudomonas aeruginosa on CFTR channel expression, function and rescue in human airway epithelial cells","volume":"7","author":"Maill\u00e9","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2024102103101166000_61.4.2201307.125","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.09.011"},{"key":"2024102103101166000_61.4.2201307.126","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00314.2012"},{"key":"2024102103101166000_61.4.2201307.127","doi-asserted-by":"crossref","first-page":"e123467","DOI":"10.1172\/jci.insight.123467","article-title":"Influenza-mediated reduction of lung epithelial ion channel activity leads to dysregulated pulmonary fluid homeostasis","volume":"3","author":"Brand","year":"2018","journal-title":"JCI Insight"},{"key":"2024102103101166000_61.4.2201307.128","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2014-0263OC"},{"key":"2024102103101166000_61.4.2201307.129","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.3390\/cells10112844","article-title":"CFTR protein: not just a chloride channel?","volume":"10","author":"Hanssens","year":"2021","journal-title":"Cells"},{"key":"2024102103101166000_61.4.2201307.130","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2010.07.002"},{"key":"2024102103101166000_61.4.2201307.131","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1491"},{"key":"2024102103101166000_61.4.2201307.132","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0910061"},{"key":"2024102103101166000_61.4.2201307.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.02.003"},{"key":"2024102103101166000_61.4.2201307.134","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2248oc"},{"key":"2024102103101166000_61.4.2201307.135","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2007.0659"},{"key":"2024102103101166000_61.4.2201307.136","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201210-1843CI"},{"key":"2024102103101166000_61.4.2201307.137","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2948"},{"key":"2024102103101166000_61.4.2201307.138","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-52"},{"key":"2024102103101166000_61.4.2201307.139","doi-asserted-by":"crossref","first-page":"L11","DOI":"10.1152\/ajplung.00328.2019","article-title":"Airway remodeling in ferrets with cigarette smoke-induced COPD using \u00b5CT imaging","volume":"319","author":"Stanford","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102103101166000_61.4.2201307.140","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23247"},{"key":"2024102103101166000_61.4.2201307.141","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jcf.2017.06.005","article-title":"Bicarbonate in cystic fibrosis","volume":"16","author":"Kunzelmann","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102103101166000_61.4.2201307.142","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120562"},{"key":"2024102103101166000_61.4.2201307.143","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0234OC"},{"key":"2024102103101166000_61.4.2201307.144","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00946-2020"},{"key":"2024102103101166000_61.4.2201307.145","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.3390\/ijms21176379","article-title":"Airway inflammation and host responses in the era of CFTR modulators","volume":"21","author":"Keown","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024102103101166000_61.4.2201307.146","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24530"},{"key":"2024102103101166000_61.4.2201307.147","doi-asserted-by":"publisher","DOI":"10.1016\/S1526-0550(02)00005-7"},{"key":"2024102103101166000_61.4.2201307.148","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-2920.2011.02459.x"},{"key":"2024102103101166000_61.4.2201307.149","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028241"},{"key":"2024102103101166000_61.4.2201307.150","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1038\/s41598-019-52726-0","article-title":"Optimal environmental and culture conditions allow the in vitro coexistence of Pseudomonas aeruginosa and Staphylococcus aureus in stable biofilms","volume":"9","author":"Cendra","year":"2019","journal-title":"Sci Rep"},{"key":"2024102103101166000_61.4.2201307.151","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/genes11050536","article-title":"The microbiome in cystic fibrosis pulmonary disease","volume":"11","author":"Fran\u00e7oise","year":"2020","journal-title":"Genes"},{"key":"2024102103101166000_61.4.2201307.152","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaci.2020.02.040","article-title":"The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease","volume":"147","author":"Dicker","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2024102103101166000_61.4.2201307.153","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13032"},{"key":"2024102103101166000_61.4.2201307.154","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1714373115"},{"key":"2024102103101166000_61.4.2201307.155","doi-asserted-by":"publisher","DOI":"10.1038\/srep22493"},{"key":"2024102103101166000_61.4.2201307.156","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00832-2017"},{"key":"2024102103101166000_61.4.2201307.157","doi-asserted-by":"crossref","first-page":"548613","DOI":"10.3389\/fcimb.2021.548613","article-title":"Changes in the cystic fibrosis airway microbiome in response to CFTR modulator therapy","volume":"11","author":"Yi","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2024102103101166000_61.4.2201307.158","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1120577109"},{"key":"2024102103101166000_61.4.2201307.159","doi-asserted-by":"publisher","DOI":"10.1038\/srep10241"},{"key":"2024102103101166000_61.4.2201307.160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008251"},{"key":"2024102103101166000_61.4.2201307.161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061176"},{"key":"2024102103101166000_61.4.2201307.162","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201609-1954OC"},{"key":"2024102103101166000_61.4.2201307.163","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2011.02130.x"},{"key":"2024102103101166000_61.4.2201307.164","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu944"},{"key":"2024102103101166000_61.4.2201307.165","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201404-0703OC"},{"key":"2024102103101166000_61.4.2201307.166","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MCP.0000000000000755","article-title":"Obstructive lung diseases and allergic bronchopulmonary aspergillosis","volume":"27","author":"Muthu","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"2024102103101166000_61.4.2201307.167","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00162912"},{"key":"2024102103101166000_61.4.2201307.168","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00418-2020"},{"key":"2024102103101166000_61.4.2201307.169","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.2147\/COPD.S141695","article-title":"Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD","volume":"12","author":"Everaerts","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102103101166000_61.4.2201307.170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030851"},{"key":"2024102103101166000_61.4.2201307.171","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00335.2013"},{"key":"2024102103101166000_61.4.2201307.172","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201906-1190PP"},{"key":"2024102103101166000_61.4.2201307.173","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00025.2015"},{"key":"2024102103101166000_61.4.2201307.174","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.mayocp.2021.03.016","article-title":"Why we should target small airways disease in our management of chronic obstructive pulmonary disease","volume":"96","author":"Usmani","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2024102103101166000_61.4.2201307.175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12931-019-1017-y","article-title":"The pathology of small airways disease in COPD: historical aspects and future directions","volume":"20","author":"Higham","year":"2019","journal-title":"Respir Res"},{"key":"2024102103101166000_61.4.2201307.176","first-page":"1191","article-title":"Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease","volume":"10","author":"Pisi","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102103101166000_61.4.2201307.177","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.chest.2020.11.018","article-title":"Interrelationships among small airways dysfunction, neutrophilic inflammation, and exacerbation frequency in COPD","volume":"159","author":"Day","year":"2021","journal-title":"Chest"},{"key":"2024102103101166000_61.4.2201307.178","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1600OC"},{"key":"2024102103101166000_61.4.2201307.179","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12967-018-1635-z","article-title":"Roles of airway smooth muscle dysfunction in chronic obstructive pulmonary disease","volume":"16","author":"Yan","year":"2018","journal-title":"J Transl Med"},{"key":"2024102103101166000_61.4.2201307.180","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200605-126SF"},{"key":"2024102103101166000_61.4.2201307.181","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41467-022-28062-9","article-title":"Characterization of the COPD alveolar niche using single-cell RNA sequencing","volume":"13","author":"Sauler","year":"2022","journal-title":"Nat Commun"},{"key":"2024102103101166000_61.4.2201307.182","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118199"},{"key":"2024102103101166000_61.4.2201307.183","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphar.2016.00275","article-title":"CFTR modulators: shedding light on precision medicine for cystic fibrosis","volume":"7","author":"Lopes-Pacheco","year":"2016","journal-title":"Front Pharmacol"},{"key":"2024102103101166000_61.4.2201307.184","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00173210"},{"key":"2024102103101166000_61.4.2201307.185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2213-2600(12)70058-9","article-title":"How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions: implications for airway hyper-responsiveness and asthma in cystic fibrosis","volume":"1","author":"McCuaig","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2024102103101166000_61.4.2201307.186","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009761"},{"key":"2024102103101166000_61.4.2201307.187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2024102103101166000_61.4.2201307.188","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"2024102103101166000_61.4.2201307.189","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0904709106"},{"key":"2024102103101166000_61.4.2201307.190","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.12.005"},{"key":"2024102103101166000_61.4.2201307.191","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00419-2019"},{"key":"2024102103101166000_61.4.2201307.192","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0228OC"},{"key":"2024102103101166000_61.4.2201307.193","doi-asserted-by":"crossref","first-page":"17834","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci Rep"},{"key":"2024102103101166000_61.4.2201307.194","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-1044-7"},{"key":"2024102103101166000_61.4.2201307.195","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010054"},{"key":"2024102103101166000_61.4.2201307.196","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"2024102103101166000_61.4.2201307.197","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jcf.2016.09.003","article-title":"Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation","volume":"15","author":"Sermet-Gaudelus","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2024102103101166000_61.4.2201307.198","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1210\/clinem\/dgaa890","article-title":"The effects of ivacaftor on bone density and microarchitecture in children and adults with cystic fibrosis","volume":"106","author":"Putman","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2024102103101166000_61.4.2201307.199","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12931-017-0656-0","article-title":"Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice","volume":"18","author":"Raju","year":"2017","journal-title":"Respir Res"},{"key":"2024102103101166000_61.4.2201307.200","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-18"},{"key":"2024102103101166000_61.4.2201307.201","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0068-2019"},{"key":"2024102103101166000_61.4.2201307.202","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S2213-2600(16)30047-9","article-title":"Pilot evaluation of ivacaftor for chronic bronchitis","volume":"4","author":"Solomon","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102103101166000_61.4.2201307.203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.06.008"},{"key":"2024102103101166000_61.4.2201307.204","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215982110"},{"key":"2024102103101166000_61.4.2201307.205","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01581-2021"},{"key":"2024102103101166000_61.4.2201307.206","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcf.2020.11.002","article-title":"Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)","volume":"20","author":"Kazani","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2024102103101166000_61.4.2201307.207","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2147\/COPD.S257474","article-title":"Efficacy and safety of the CFTR potentiator icenticaftor (QBW251) in COPD: results from a phase 2 randomized trial","volume":"15","author":"Rowe","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102103101166000_61.4.2201307.208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1513\/AnnalsATS.201909-671CME","article-title":"The extrapulmonary effects of cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis","volume":"17","author":"Sergeev","year":"2020","journal-title":"Ann Am Thorac Soc"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01307-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T01:12:08Z","timestamp":1740359528000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01307-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":208,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,1]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1183\/13993003.01307-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01307-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]}}}